Xcout Intel
Enara Bio, Ltd.
Enara Bio is a biotechnology company headquartered in Oxford, Oxfordshire, backed by prominent life science investors. The company focuses on advancing cancer immunotherapy by targeting novel Dark Antigen assets.
Subscribe to see Enara Bio, Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enara Bio, Ltd. at a glance
Enara Bio, Ltd. is a biotech company headquartered in United Kingdom. Xcout tracks 15 named people at Enara Bio, Ltd., including Kevin Pojasek (President and CEO). Xcout recorded 2 job postings from Enara Bio, Ltd. in the last 90 days.
Enara Bio, Ltd. leadership
- Kevin PojasekPresident and CEO
- Stacey DavisCBO and CFO
- Joseph DukesCSO
- Scott DrutmanCMO
- Mike QuigleySanofi CSO and Global Head of Research Ex-Gilead and BMS R&D
- Drew Pardoll, MD, PhDCo-founder of Enara Bio
9 more named people on record for Enara Bio, Ltd., with roles, board committees and tenure — see the full roster →
Hiring at Enara Bio, Ltd.
Xcout recorded 2 job postings from Enara Bio, Ltd. in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Enara Bio, Ltd.'s hiring signals →
Tech stack
Enara Bio, Ltd. competitors
A few of Enara Bio, Ltd.'s closest competitors — see the full list of competitors and alternatives →
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, United Kingdom, focused on early oncology research before being acquired by Amgen.
Epitopea is a transatlantic cancer immunotherapeutics company operating from Montreal, Canada, and Cambridge, United Kingdom. Backed by life-science investors, the company develops novel therapeutics utilizing its proprietary CryptoMap platform.
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Get Enara Bio, Ltd.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Enara Bio, Ltd.? Suggest a correction · Work at Enara Bio, Ltd.? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Enara Bio, Ltd. in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access